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Abstract
Background: The use of research evidence in health policymaking is an international challenge. Health systems,
including that of Israel, are usually characterized by scarce resources and the necessity to make rapid policy
decisions. Knowledge transfer and exchange (KTE) has emerged as a paradigm to start bridging the “know-do” gap.
The purpose of this study was to explore the views of health system policymakers and senior executives involved in
the policy development process in Israel regarding the role of health systems and policy research (HSPR) in health
policymaking, the barriers and facilitators to the use of evidence in the policymaking process, and suggestions for
improving the use of HSPR in the policymaking process.
Methods: A survey and an interview were verbally administered in a single face-to-face meeting with health system
policymakers and senior executives involved in the policy development process in Israel. The data collection period
was from July to October 2014. The potential participants included members of Knesset, officials from Israel’s Ministry
of Health, Ministry of Finance, health services organizations, and other stakeholder organizations (i.e., National Insurance
Institute). The close-ended questions were based on previous surveys that had been conducted in this field. Interviews
were tape recorded and transcribed. Descriptive statistics were conducted for close ended survey-questions and
thematic analysis was conducted for open-ended interview questions.
Results: There were 32 participants in this study. Participants felt that the use of HSPR helps raise awareness on policy
issues, yet the actual use of HSPR was hindered for many reasons. Facilitators do exist to support the use of HSPR in
the policymaking process, such as a strong foundation of relationships between researchers and policymakers.
However, many barriers exist such as the lack of relevance and timeliness of much of the currently available research to
support decision-making and the paucity of funding to support research use. Suggestions to improve the use of HSPR
focused on improving dissemination of research findings and ensuring that the research was more relevant and timely.
Conclusions: This research demonstrated that health systems policymakers in Israel perceive having strong
relationships and collaborations with researchers however there is room for improvement, e.g. partnering in
research projects to ensure relevance and use. Furthermore, health system policymakers seem to be interested
in receiving relevant research in a more useable format and are open to using research in decision making.
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Background
There is international awareness about the need to bridge
the gap between research, practice and policy [1–6]. For
close to a decade calls have been made to implement ini-
tiatives that link research to action. Knowledge transfer
and exchange (KTE) has emerged as a paradigm to start
bridging the “know-do” gap [7]. KTE is defined as “a dy-
namic and iterative process that includes synthesis, dis-
semination, exchange and ethically-sound application
of knowledge to improve the health of [citizens], pro-
vide more effective health services and products and
strengthen the health care system” [8]. While there
are some excellent examples of effective links between
research and decision making [9–11], there are still
many challenges in using health systems and policy
research to inform policy.
One of the main challenges that countries face in KTE
is developing and using effective strategies to promote
the use of research in policymaking [12, 13]. The two
predominant actors in the KTE process are knowledge
producers i.e. researchers and academics, and knowledge
users i.e., managers and policymakers. Both knowledge
producers and knowledge users have initiatives that they
can undertake to support the use of research in policy-
making. Knowledge producers produce the research, and
if the research is not relevant, packaged in ways that
highlight decision relevant information or readily access-
ible when decision makers need it, then the likelihood of
decision makers utilizing the research evidence is poor
[14–17]. Other barriers also exist to the use of research
evidence in policymaking, for example academic research
is frequently written in academic jargon and traditional
scientific formats, and is not packaged or disseminated in
a user-friendly manner [18, 19]. Numerous initiatives that
researchers can undertake to support KTE have been pro-
posed and studied, such as having researchers ‘push’ the
research out through different channels, facilitating the
use of research by ensuring that research is more readily
available when it is needed and in a form that is easy to
use, and utilizing knowledge brokers and other mecha-
nisms to support linkage and exchange [20–22].
Knowledge users, such as policymakers, also have a
role to play in the use of research. While research evi-
dence may only be one of many factors within the deci-
sion and policy making process, there is an increasing
awareness of its value [23]. Health system policymakers
are required to make important and costly health system
decisions related to the governance, financial, and deliv-
ery arrangements that determine whether the right pro-
grams, services and drugs get to those who need them
[24]. Policymakers need to be open and receptive to evi-
dence informed policymaking and they are integral to
setting the climate for research use. Furthermore, if
knowledge users do not know how to acquire, assess or
apply the research evidence, and if they do not imple-
ment infrastructures that support the use of evidence,
then the likelihood of using research evidence to inform
policymaking will be poor. Lavis et al, and further reiter-
ations of his framework [4, 20, 25], highlight some ac-
tions that policymakers can undertake in order to
facilitate evidence informed policy making, such as train-
ing and implementing decision making processes that
support the use of research evidence.
The success of any KTE strategy is dependent on tai-
loring the approach and initiatives that are implemented
to the local context and the barriers and facilitators op-
erating in these contexts [4, 25–27]. Understanding the
local context and the views of the main actors in the
process can assist in identifying the barriers and facilita-
tors for KTE. Governments and international agencies
provide recommendations and implement policies which
they claim to be based on the best available evidence at
the time. However, studies have shown that in many
cases, these recommendations are not based on the best
available evidence and there are gaps between the evi-
dence that was available at the time a recommendation
was made and the recommended action [28, 29].
While research in the area of KTE and understanding
the views of key actors in the process and actual use of
research in policymaking has been conducted in Canada,
some Arabic countries, and elsewhere, [3, 13, 23, 30, 31],
minimal work has been done in this area in Israel. The
use of research evidence in health policymaking is an
international challenge. Health systems, including that of
Israel, are usually characterized by scarce resources and
the necessity to make rapid policy decisions. The Israeli
health system is based on the national health insurance
(NHI) law, instituted in 1995, that provides every Israeli
resident with a basic package of health care, i.e. universal
health coverage. The main components of the Israeli
health system are the Ministry of Health (MOH), four
health insurance funds and other non-profit organiza-
tions. The MOH has overall responsibility for the health
of the population and the effective functioning of the
health care system. The system is financed through tax-
ation linked to income and accounts for approximately
8 % of the GDP [32, 33]. In Israel, the high level policy
makers (e.g., the Minister of Health) change frequently
and may be limited in their knowledge or experience
with certain health policy and system issues. However,
those that support policymakers and senior executives
involved in the policy development process in Israel,
have the organizational memory, remain in their post for
longer periods of time, and can support KTE initiatives
and incorporate HSPR to inform policy. Due to the fact
that policymakers are changing often, the culture and
processes need to be implemented to support KTE and
the approach to KTE and HSPR needs to be suitable to
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both policymakers, those that support policymakers, and
senior executives involved in the policy development
process in Israel.
Additionally, Israel is a small country with a lot of in-
ternal diversity. This means that there may be difficulty
in conducting research on policy-type interventions
since there can be a problem with the small “sample
size” and generalizability. In addition, Israel faces dis-
economies of scale; it has just as many national policy is-
sues as much larger countries, but far fewer researchers
to study these issues. Thus, it is even more important
for researchers and policy makers to be more coordi-
nated, and also be able to use research from other coun-
tries as a basis, that can then be assessed, adapted and
applied to the Israeli context.
Previous research has been published that examines
the experiences related to KTE in Israel of researchers
who have conducted health systems and policy research
in Israel. Most researchers that conduct health systems
research in Israel are based either in research institutes,
academic institutions, government agencies, the four
health insurance funds, or hospital settings, and many
researchers have cross appointments in a number of the
aforementioned institutions. This previous research has
demonstrated that less than half of the respondents were
involved in various KTE activities such as interacting
with knowledge users throughout the research process
and developing reports and summaries that used lan-
guage appropriate for their target audiences [34]. More
than a third of the researchers in Israel reported that
they were frequently or always involved in interactions
with target audience through the research process (i.e.
during developing a research question or executing the
research) or through formal or informal meetings during
conferences, workshops or conversations. However, less
than half of the researchers stated that they were en-
gaged in bridging activities aimed to facilitate target au-
diences to use research [34]. While there is engagement
from the researchers in Israel, it is important to note
that health system researchers are only one part of the
equation when it comes to ensuring the use of research
in health policymaking. Policymakers in the health sys-
tem also play an important role in the use of research
evidence to inform their decisions. Previous research in
Israel has documented the reforms made to the health
system as well as the potential role of data to inform
policymaking. While the research did demonstrate that
data use increased over time and decision makers did
rely on data, at times key data were missing and further-
more, the policymakers rarely explored in a systematic
way how data could contribute to the decisions they
face. In addition, one study found that even where the
intention may be to use data to inform policymaking,
political motives are also a strong force [35, 36]. The
purpose of this research was to explore the views of
health system policymakers and senior executives in-
volved in the policy development process in Israel re-
garding the role of health systems and policy research
(HSPR) in health policymaking, the barriers and facilita-
tors to the use of evidence in the policymaking process,
and suggestions for improving the use of HSPR in the
policymaking process.
Methods
A survey and an interview were verbally administered in
a single face-to-face meeting with health system policy-
makers and senior executives involved in the policy de-
velopment process in Israel policymakers in Israel.
Study population
The survey population consisted of Israeli health ser-
vices policy makers. This definition included those who
are involved directly in health policy making as well as
those who support these processes (i.e.: those who con-
sult with policy makers or support them with relevant
information such as CEOs, managers or heads of differ-
ent governmental departments and councils). Individuals
who fit these criteria and who were involved in the last
five years in at least one health policymaking process in
the Israeli health system, were eligible to participate.
Selecting the sample
It was estimated that there are approximately 60 individ-
uals who can be considered to be health services policy-
makers or in support roles for these policymakers in
Israel. Therefore it was decided that all potential partici-
pants will be invited to take part in the survey. The list
of potential participants was identified through four
main avenues: 1) searching publicly available web sites
(e.g.: Israel’s Ministry of Health) to identify individuals in
appropriate positions, 2) consulting with leaders in the
health policy arena who are familiar with the health
policy making landscape in Israel, 3) contacting the
National Institute for Health Policy to determine if they
could identify additional participants, and finally, 4)
using a respondent-driven sampling technique (i.e., ask-
ing participants at the completion of the interview if
they can identify any additional participants that may
have relevant information for our study). The sampling
frame was purposefully broad to ensure that all potential
participants were captured: therefore the survey may
have been applicable to a smaller number of participants
than what was sent out.
The final list of potential participants included officials
from the following: the Knesset, Israel’s Ministry of
Health (CEO, heads of divisions and departments, dep-
uty directors and heads of national councils); Ministry of
Finance; health services organizations (CEOs and vice
Ellen et al. Israel Journal of Health Policy Research  (2016) 5:24 Page 3 of 15
presidents); and other organizations (medical centers
Hospitals CEOs, National Insurance Institute of Israel’s
CEO, Israel Medical Association; members of the
Knesset).
Developing the survey and interview guide
The survey was based on a survey that has been tested
and has shown high internal consistency and good face
and content validity [37], which itself formed the basis
of other surveys that have been conducted in this field
[3, 30]. However, this version was lengthy and was there-
fore modified and adapted to the Israeli context. The
survey tool focused on: a) factors that have an effect on
the health policy making process, b) barriers to use
HSPR by policy makers, c) linkage and exchange activ-
ities between researchers and decision makers/policy
makers, and d) views on KTE [3, 13]. The surveys con-
sisted of a demographics section and closed ended ques-
tions, with response options on quantitative scales. The
response options to the quantitative scales were given
on ordinal scale ranging from 1 to 5 (were: 1 = “strongly
disagree” and 5 = “strongly agree”) with a middle neutral
category (3 = “neither agree nor disagree”). The inter-
views consisted of open ended questions that focused on
the barriers and facilitators to using evidence to inform
policymaking and suggestions to improve the usage of
HSPR as part of the policy making process.
The survey and interview tools were translated into
Hebrew using the process recommended by the World
Health Organization [38]. First, the tools were forward
translated to Hebrew by a researcher familiar with the
terminology of the area covered by the survey and inter-
view. Second, the tools were back translated to English
by an independent translator whose mother tongue is
English. Third, both versions (English and Hebrew) were
given to a bilingual expert in order to resolve the inad-
equate expressions/concepts of the translation. Finally,
the Hebrew translation was corrected to its final version.
Recruiting the sample and administering the survey and
interview
An initial email, in Hebrew, was sent out to all potential
participants inviting them to participate in the study.
The letter described the purpose of the study and offered
the recipients the opportunity to participate voluntarily
in the study and contribute based on their experience.
Recipients were also told that the survey and interview
can take place at their work place or another location
that is convenient for them. A second reminder was
sent two weeks after the initial request, followed by a
third reminder which was sent a month later. Those
who did not respond to the third reminder were con-
tacted by phone.
Both the survey and the interview were conducted in a
single face-to-face meeting and the latter was recorded
and transcribed. The interviews took place at the loca-
tion most convenient for the participants, which most
often was their workplace. Participants were asked to
sign a consent form and were assured that all responses
would be anonymized. The data collection period was
approximately four months (July to October 2014).
Data analysis
All the quantitative responses were exported to the Statis-
tical Package for Social Sciences (SPSS) and analyzed
using descriptive statistics. Descriptive analyses were con-
ducted for closed-ended questions. For close-ended ques-
tions about views on the barriers and facilitators to use
HSPR we combined the two highest response options.
The interview data were analysed using a constant
comparative method for the thematic analysis. Two re-
searchers independently read and coded the transcripts.
First we read the entire interview transcript to get a
sense of the whole interview and initial impressions.
Then we read the text a second time, coded units of
text, and compared initial codes. Coded segments were
then re-analysed, coded into subcategories, and com-
pared again.
The study received ethics exemption from the
Jerusalem College of Technology’s ethics committee.
Results
A total of 73 potential respondents were contacted; three
of them did not meet the criteria for participation in the
study. 32 policy makers were surveyed and interviewed
(response rate of 46 %). Non-response was due to the
following reasons: 4 refused, 26 did not respond to our
initial contact and subsequent letters, and 8 potential re-
spondents agreed to participate but could not commit to
an interview during the time frame of study. Among the
32 respondents, 23 were males and 9 females. The aver-
age age of the respondents was 54.7 (SD 11.3) years. The
age range was 34 to 83 years. The response rate was
higher for respondents working for government than for
other organizations and the response rate was lower for
the ministers, director-generals and CEOs than for other
positions. The set of respondents has a greater concentra-
tion of government employees, and a lower concetration
of top-ranking officials than did the study population.
56 % (18) of participants were from the Ministry of
Health, 12.5 % (4) each from health service organizations
and national councils, and the remainder from other orga-
nizations such as hospitals, the national insurance
institute, the Israel Medical Association, the Ministry of
Finance and members of the Knesset. 16 % (5) of the re-
spondents were either Ministers, current or past director-
generals of the ministry of health, or CEOs, 28 % (9) of
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the respondents were deputy director-generals or vice-
presidents, and 56 % (18) were in other positions i.e., de-
partment heads or chairpersons of national committees
(see Table 1).
Quantitative analysis of survey questions
Views on the role of HSPR in influencing the health
policymaking process
Respondents indicated that there are both significant bar-
riers and important facilitators in the real-world applica-
tion of HSPR in Israel. Most respondents felt that the use
of HSPR was hindered due to practical constraints such as
financial implications and just over half felt that it was
hindered due to politically sensitive findings (Table 2).
About two thirds of respondents agreed that evidence
from HSPR does help policymakers identify and/or choose
policy alternatives, which reflects and implies an actual
use of research, and close to half of the participants stated
that evidence from HSPR does help raise awareness on
policy issues. Yet, only a quarter of participants felt that
evidence was presented to them in a timely manner or in
a format that was easily understandable.
Views on the barriers and facilitators for KTE activities
More than two thirds of the participants felt that the
national funding organizations formulated their fund-
ing calls in response to regional and national needs
and that national funding sources support KTE activ-
ities (Table 3). Most participants also agreed that
there were structures and processes in place to link
them with researchers and that they had the neces-
sary skills to acquire, assess, adapt and apply the
relevant research. Less than half of the participants
felt that there were significant barriers in place to
prevent the use of HSPR. Less than half of respon-
dents felt that organizations that conduct HSPR
assisted with KTE activities by making financial and
human resources available to assist in the transfer
and exchange of knowledge (Table 4). Less than half
of the participants felt that the currently available re-
search aligns with the needs of the knowledge users
and that the currently available research aligned with
the country’s priorities (Table 5).
Views of what influences the health policymaking process
in Israel
Most respondents felt that broad challenges in intergov-
ernmental (i.e. Ministry of Health, Ministry of Finance)
relations hindered the health policymaking process and
more than half felt that broad challenges in government/
provider relations hindered the health policymaking
process (Table 6). The four main influencing factors that
were perceived to have exerted the strongest influence
on the health policymaking process were limited health
funding, health insurance funds, the media, and phys-
ician associations (Table 7).
Table 1 Composition of the set of potential respondents
compared to the actual respondents by organization type and
level in the organization
Potential
Respondents (n)
Actual
Respondents (n)
Response
Rate (%)
Organization Type
Government
(MOH, MOF, etc.)
39 20 51 %
Non-government 34 12 35 %
Level in the organization
Ministers,
director-generals,
CEOs
18 5 28 %
Deputy
director-generals/VPs
17 9 53 %
Others (includes
department heads,
chairpersons of national
committees and other)
38 18 47 %
Total 73 32 44 %
Table 2 The role of HSPR and the factors that influence the use
of HSPR by health policymakers and stakeholders Israel
Percentage Agree
or Strongly Agree
Use of evidence from HSPR in
policy was hindered by practical
constraints to implementation
such as financial implications
91
Evidence from HSPR does help
health policy makers and stakeholders
to identify and/or choose policy
alternatives
63
Use of evidence from HSPR in policy
was hindered by findings that were
politically sensitive or were inconsistent
with a policy direction
52
Evidence from HSPR does help raise
health policy makers and stakeholders’
awareness on policy issues
49
Use of evidence from HSPR in policy
was hindered by a non- receptive
policy environment
34
Lack of coordination between policy
makers and researchers hindered the
use of evidence from HSPR in the
health policymaking process
32
Evidence from HSPR was presented
to policy makers and stakeholders
in a timely manner and in a format
that they can understand
25
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Qualitative analysis of interview questions
Barriers and facilitators to the use of HSPR in policymaking
The main barrier that was mentioned by all participants
related to the lack of timeliness, dissemination, and rele-
vance of the research (Table 8). With respect to the
dissemination of the research, all participants felt that
the research was often not timely and therefore it was
frequently not relevant i.e., “there is a kind of delay be-
tween the decision making and when you get… the evi-
dence sometimes comes too late, so it, at most, confirms
the decisions you already made, but many times there is
nothing to rely on”. This could be either because of the
time it takes to conduct the research, the speed with
which decisions need to be made, or the delay between
conducting the research and making the research pub-
licly available.
With respect to the actual research, most participants
felt that at times, the research was not relevant and did
not match the needs of policymakers i.e., “the research
does not always answer the question exactly. I mean, it
is broader or narrower, it looks from another angle, so it
does not always answer the question that arises at the
moment.” Furthermore, participants felt that many times
while there may be research that answers similar ques-
tions from other countries, it was not relevant for the
Israeli context since Israel’s climate, context and culture
is different and therefore other country’s research cannot
easily be adapted. For example, one participant stated
that it’s “very difficult to rely on policy studies from
Table 3 Potential facilitators and barriers to the use and
implementation and use of KTE activities
Percentage Agree
or Strongly Agree
Facilitators:
National funders formulate their priorities
and calls for proposals in response to
national and regional needs.
78
National funding sources encourage
KTE activities.
69
Structures and processes exist to link
you with researchers
68
Policymakers have access to technical
support for acquiring, assessing, and
applying HSPR research
68
Funding sources (e.g., granting agencies)
consider KTE activities an allowable expense
65
Personal and organizational contacts among
policymakers and researchers were quite
stable over time
61
Policymakers create opportunities to develop
joint HSPR research initiatives with them
45
Policymakers invest financial and/or human
resources in joint HSPR research initiatives
with them
45
Policymakers invest financial and/or human
resources in KTE activities
42
Barriers:
Priorities in the health system draw attention
away from HSPR research
43
Policymakers lack the expertise for acquiring,
assessing, and applying HSPR research
31
Policymakers do not make decisions on the
basis of HSPR research
24
Policymakers do not have technical access
(i.e. journal subscriptions, links to research)
to the appropriate databases to search for
HSPR research
10
Table 4 Additional facilitators and barriers at the level of
organizational support for KTE activities
Percentage Agree
or Strongly Agree
Organizations that conduct HSPR made
available financial and human resources
to assist with KT activities
46
KT was hampered by a lack of incentives
for KT activities within organization’s
that conduct HSPR
15
Organizations that conduct HSPR were
not seen as a credible source of research
7
Table 5 Alignment of available research to needs of knowledge
users
Percentage Agree
or Strongly Agree
Available research coincided with my
country’s priorities (e.g., with a National
Research Agenda)
48
Available research coincided with the
needs and expectations of target
audiences
37
Available research was not considered
relevant by policymakers
11
No research was ready for use 4
Available research lacked credibility
among target audiences
0
Table 6 Factors that influence health policymaking in Israel
Percentage Agree
or Strongly Agree
Broad challenges in intergovernmental
(i.e. Ministry of health, Ministry of Finance)
relations hindered the health policymaking
process.
91
Broad challenges in government/provider
relations hindered the health policymaking
process.
59
Policy formulation is usually based on internal
Ministry of Health discussions and ad hoc
process rather than evidence based processes
34
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countries that have a completely different health system
[…]. So the adaptations we need to make are very com-
plex, which makes the research not always relevant.”
Many respondents also cited the typically ineffective dis-
semination methods as a barrier, either in the packaging
(i.e., “Sometimes we need a bottom line … So what are
the conclusions and what are the recommendations”) or
the channel (i.e. academic journals) that the research is
disseminated. Another barrier that was mentioned many
times was the logistical limitation or inability to make
the changes in the organizations.
Some participants felt that the positions taken by dif-
ferent stakeholder groups, such as industry, and the ‘pol-
itical agenda’ were barriers. It was felt that “if research
does not fit with their (policymakers) perception, so they
ignore it”. Other participants also felt that policymakers’
pre-conceived notions regarding the decision making
process and the inclusion of research in that process
were major barriers to the use of HSPR in decision
Table 7 Groups or factors that exert a strong influence on the
health policymaking process
Percentage Agree
or Strongly Agree
Limited health funding (the economy) 100
Health insurance funds 77
Media 71
Physician associations 59
Values of governing parties 41
Public opinion 38
Other countries’ health policies 36
Nursing associations 30
Other types of health professional
associations
20
Research about problems related to
healthcare or health systems
19
Donor organizations 3
Table 8 Representative quotes on the barriers to the use of HSPR in health policymaking/decision making in Israela
Theme Representative quotes
1. Barriers related to the actual research
and dissemination of the research
• The research is not timely The time from when the study was conducted until it was published. This is a general problem with
research – it takes too long until they are published and it is unclear that the data is still relevant to current
reality.
One of the problems is that it is very rare that you have the information you want. The problem is you
want to get information, information that you don’t have, and do not have time to wait for it. Most of the
studies that I see come after the fact, and this is 20/20 hindsight.
• The research is not always relevant i.e.
the research question does not match
the need
[Researchers] don’t always ask us what we need to know, what are the issues that interest us, before
planning the research. Then they come and say, “Use this,” but we do not need it.
• Research from other countries is not
always applicable
Discrepancies between international research and international data and the situation in Israel
Doubts about the relevance of studies and data from overseas to the unique situation in this country,
requires self-examination, [that] cannot always be done.
• Concerns regarding the type of
research and the quality of research
Research where it is not clear what was their methodology… I want to see the methodology of the study
to see how much I can trust it, critically, and if I do not have access to the methodology, it makes it difficult
for me.
• Dissemination of the research results Studies get published but they remain at the level of articles and conferences, but they don’t break down
into the particulars to examine applicability.
2. The ability to make the change in
the organization
We have a highly structured health system with a particular structure where it is not always easy to
implement, to fit some things to the evidence, in a framework where it’s very difficult to make changes in
the structure of our system.
3. Interests from different stakeholders
(including political agenda)
There are all sorts of considerations for the HMOs in implementing… especially of the doctors and,
definitely, of the government.
Barriers of personal views, of politics, the media, the pressures from voters, the wealthy.
Some will adopt this wholeheartedly. If it fits with your doctrine, then it’s very good to come out and say “I
just happened to find …”.
4. Policymakers’ preconceived notions
regarding decision making and
attitudes towards research
People have preconceptions about what should be done, no matter what the study shows.
The main problem is that policy makers in Israel do not want to make decisions based on data, and
certainly in cases where the data do not support their gut feelings, their ideology, their tradition … don’t
want to hear, don’t want to implement, don’t want to internalize it.
5. Policymakers’ understanding of the
research
Many of the policy makers do not know how to read research … social research, which is what create
policies, add other variables to the picture, variables that doctors don’t have a clue. They sometimes do not
even realize their importance.
aThe themes in the table are presented from the most to the least common themes mentioned in the interviews
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making. Some participants felt that “policymakers [think
they] know everything” and that it has become the norm
for decisions to be “based on personal preferences and
on the basis of subjective understanding of reality, this is
the tradition that exists in Israel.”
Finally, it was felt that at times, many different individ-
uals are working on the same issue in such a small coun-
try at the same time and there is a “situation in which a
lot of people are working on the same thing in parallel
without interaction – there is no communication within
the Ministry of Health, outside the Ministry of Health,
in the HMOs themselves. And that, I would not say “full
gas in neutral” but why do we need to use four cars at
the same time if you can put them all in the same car so
they can go together? Lack of communication between
the relevant parties creates a situation where you are
sometimes not aware of the existing policy- by the time
you are aware of it, you suddenly discover that you are
too late. So you say, “I was working on this, I tried to
lead something, and in fact it already exists”. Because
people forget they have to pass on the information on
policies”. This lack of communication and alignment
acts as a barrier to the use of the appropriate informa-
tion when developing policies.
Most participants felt that the main facilitator to the
use of research in policymaking and decision making
was the collaboration and relationships between re-
searchers and policymakers (Table 9). Different forms of
collaboration were mentioned such as ensuring experts
are included in the decision making process i.e., “It’s that
there is a professional in this decision-making process
that is critical. Decision-making is not carried out by
those who don’t know how to read research.” Another
form of collaboration was having round tables with the
National Institute for Health Policy (NIHP) i.e., “Round
tables at the healthcare system level that can be a place
for raising needs and requirements. For example, meet-
ings of the NIHP, which happens each year, where they
collect number of issues and address them; and those
who participate in it include academics, and policy
makers, and officials from sick funds, so there is discus-
sion and dialogue within the country.”
The next main facilitator that was mentioned was re-
lated to the actual research such as ensuring that the re-
search outlines the relevance of the study results to
Israel i.e., “Research that relates to the population in
Israel is by nature better able to influence policy than
general research.” Outside pressure from both the public
and the media was also viewed as a facilitator to support
the use of research in decision making. Some respon-
dents felt that a strong facilitator to the use of research
in decision making is the existing culture and that there
is a “general approach to try to base decisions on facts.”
This could be because some decision makers have a
background in research and they institute this type of
culture in their departments i.e., “People who came from
Table 9 Representative quotes on the facilitators to the use of HSPR in health policymaking/decision making in Israela
Theme Quotes to support
1. Collaboration and relationships
between researchers and policymakers
A small country, where there are many connections between people, so they have many opportunities
for sharing information and transferring ideas etc. That helps…
Since there is the Knesset Research and Information Center, we have a better ground for work on,
because the work is based on data and not only on intuition or biased knowledge that is only based on
my life-experience, and I don’t know other people’s life experiences well enough.
Combination of researchers who are also involved in clinical work, i.e. management, as well as
researchers, who can influence research directions and then get results that fit their decision making.
2. Facilitators related to the actual research
and dissemination of the research
• Outlining the relevance of the study to
Israel
Research that relates to the population in Israel is by nature better able to influence policy than general
research … The more it refers to the Israeli population, or a specific sector where the question is, then
its validity would be greater, it will have more weight.
• Type and quality of research The quality of research – relevant research, done on a large scale, with the participation of relevant
people with prestige and influence on decision makers.
Research based on administrative data is very helpful to rely on, and not only on sample and survey
data.
The quality of research which is reflected … also the methodology, even where it was published.
3. Outside pressure
• Public pressure Understanding of the need by the public, so they can come out and demonstrate and influence
decision-making
• Media pressure An increase in the prevalence of the phenomenon as is reflected in the media. Politicians are very
sensitive to the media …
4. Culture that supports the use
of research in decision-making
The great openness and the desire of decision makers, and their understanding that such studies can be
a working tool, or a tool that contributes to decision making. It’s this willingness of the decision-makers
aThe themes in the table are presented from the most to the least common themes mentioned in the interviews
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research … and create a culture of a kind of decision-
making in the offices.” Another reason for the existence
of this culture could be a spill over effect from medicine
i.e., there is an accepted culture in medicine of evidence
based practice and therefore there is an overall push that
all decisions should be based on research i.e., “the med-
ical culture – they use a lot of evidence based. There is a
push for research …”.
Main KTE activities in Israel
All participants mentioned attending both local and
international conferences as the main KTE activity in
Israel as they serve as a basis for collaboration and fu-
ture research (Table 10). Most participants mentioned
building formal relationships between researchers and
policymakers as an important KTE activity in Israel.
This included being partners in research production or
having formal meetings and collaborations to discuss
research i.e., “All the relationships we have with the re-
search institute, which is expressed by raising issues.”
Another KTE activity that was mentioned was collabor-
ation between researchers and decision makers on
committees for specific health system issues such as
i.e., wait times and quality improvement.
Suggestions to improve the use of HSPR in health
policymaking in Israel
Most participants felt that in order to improve the
use of HSPR in policymaking in Israel, the dissemin-
ation of research findings needs to be more effective
i.e., “to reach politicians – in order to speak the same
language, they need to get it in some kind of a
“nutshell”, so that they understand the significance
and importance …where it affects them, what benefit
it gives them” (Table 11). The research has to be de-
livered to the policymakers in a manner that is easy
to understand and apply. Some respondents recog-
nized that the responsibility falls on both knowledge
producers and knowledge users i.e., “Concerning the
transfer of information – it’s true not only on the
side that posts the information, but also on the re-
ceiving side. That decision-makers have someone in
charge of interactions.”
Practical suggestions were provided regarding how to
improve the dissemination of research findings i.e.,
 Consolidating the dissemination of findings and
either
o developing a website focused on health research
that will send emails with list of recent research,
associated abstracts and links to the research,
o compiling a quarterly newsletter that highlights
recent relevant research, and/or
o providing short summaries of research, not
more than 3-5 lines
 Sending concise, targeted emails with links to the
research,
 Inviting researchers to present in the decision-
makers’ organizations
 Training both knowledge producers and knowledge
users on effective dissemination and usage of
research findings
 Using knowledge brokers or leaders to disseminate
the information
Table 10 Representative quotes of main KTE activities in Israela
Theme Quotes to support the theme
1. Attending local and international conferences The presence at and support of conferences, which I think are also a good tool to design
future research. Then you report what you have done, but it’s actually the infrastructure
for the things that follow.
2. Building formal relationships
between researchers and
policymakers
• Partners in research production We’re constantly involved in research … all kinds of researchers come to us.
• Meeting to discuss research The activities of the Ministry of Health (MOH) Management with the Gertner Institute
(Institute for Epidemiology and Health Policy Research), - periodic meetings to talk
about research and what are the needs of the MOH, and what Gertner can give.
3. Collaborating on committees
for specific issues
We direct advisory committees in many fields to define quality indicators in hospitals
in Israel and carry out studies of clinical outcomes, form partnerships with relevant
scientific unions, and collaborate in studies they do and conduct our own studies…
for formulating policy, eventually.
4. Linkages with international
organizations i.e. OECD
The MoH representative in the OECD makes the integration of what is happening with
our hospital quality indicators and what is done with quality indicators around the world
and we participate in international studies as part of the OECD countries to make
international comparisons.
Meetings with international bodies such as the OECD, the World Health Organization,
conferences of all sorts.
aThe themes in the table are presented from the most to the least common themes mentioned in the interviews
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Table 11 Suggestions to improve the use of HSPR in health policymaking in Israela
Topic Quotes to support
1. Increased and more effective dissemination
of research findings to policymakers
There should be someone who connects and create this link between policymakers and researchers,
because, in this era of profusion of studies in various fields, we need to have someone to do the
integration before they submit it to policy makers.
You come to the decision maker and show him a study and he has no idea how to judge it, how
reliable it is, how valid it is, whether the methodology is correct …
Need to find form of transferring information that is convenient to policy makers.
Practical ideas re: implementation Consolidating dissemination of findings:
Once the institute has published something, send it, maybe not every month, but maybe several
times a year, every quarter … you can send abstracts … and suddenly I see that it’s something very
interesting to me and that I’m working on at the moment. I may not read it now, maybe I’ll print it
and read it later…
Some kind of a digest, a site that sends abstracts directed at policy issues, that I can choose from a
list of topics.
A quarterly, bi-annual or annual publication that collects all the articles… Whoever wrote an article
and thought it is relevant to the field of policy should send it is to this place and they can distribute
it as a news-letter once every X time, and you can see all the things that were published, and see if
you want to get into it or not. Not every time there is a new study- not something that overwhelm
people- but something they know that comes out between 1 and 4 times a year, each time an email.
And whoever wants to, can look at it.
Disseminating concise summaries of study findings:
Distributing very concise summaries by e-mail to the target audience. If it’s really an abstract- 3-5
lines- I can read it.
Inviting researchers to present in the decision-makers’ organizations
Inviting researchers to present their research work within a policy-oriented framework, i.e. to policy
makers within the organization, not in an external conference … for example, a board meeting of the
Ministry of Health or our meetings, if a researcher can came to present his work more frequently.
Training both knowledge producers and knowledge users on effective dissemination and usage of
research findings:
To train policymakers in using findings efficiently and to train the reviewers on how to correctly
present and how to fit the needs of policy makers in the way they pass on the information.
Pushing findings:
Researcher who conduct a study and has findings should push it. Publish it in all sorts of ways. There
are many ways to publish. Pushing knowledge – but pushing is something you do again and again.
You sent something and there is no response, you can send it again. Don’t be afraid to push, to be a
little aggressive in pushing knowledge that seems very important. To push it via e-mail or other kinds
of mail, or request an appointment or send it again, or remind them, if the situation arise. Marketing
the information, the knowledge, upwards and onwards.
Using knowledge brokers or leaders to disseminate the information:
Research should involve people of reputation and status that may promote this tool called research
to decision makers, including knowledge brokers.
Enabling the ability to search in national language i.e. Hebrew
A search engine in Hebrew- that I can have one in Hebrew as well, some place that collects all the
studies and then I can search … something more accessible. It does not have to be only peer-
reviewed studies, but also documents from Brookdale (Centre for Health Policy Research) and the
like…
2. Collaboration between researchers and
policymakers on research production
At the stage when they develop research, that it should kind of fit the needs, i.e. to be involved early
in the development of research so that it would answer my needs, that someone will take into
account issues and methodology that interests me. The researchers will know what is the product
that I need.
Building research together with policymakers, in advance- defining the main objective, reaching
consensus on its meaning..something that is done in advance together.
Interactions with policy makers in advance to define the questions that interest them and are still
unanswered by research. In major issues, you should also consult with them on study design, in a
way that will make it more relevant to policymakers.
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 Enabling the ability to search in the national
language i.e. Hebrew
Most participants also stated that increased collabor-
ation between researchers and policymakers on research
production can ensure the use of research in decision
making i.e. “The academy cannot be completely cut off,
if it wants to influence, if it wants to be a part of things,
it needs to connect with the decision making process at
an earlier stage.” Furthermore, providing opportunities
for official linkage and exchange between policymakers
and researchers can improve the use of research in deci-
sion making. These opportunities can occur either at
conferences or through research meetings.
However, some participants felt that conferences were
not so useful because they are very subject specific, limit
the number of participants, and are not accessible to all
due to the cost i.e. “At the Dead Sea Conference, for ex-
ample, they limit both to a specific subject and also to a
very small number of people” and “Making it so that the
conferences are not so expensive … or open them, ex-
tend more invitations to conferences.” Furthermore,
some participants felt that conferences were not so
useful i.e. “I don’t use “they said so at a conference”
when I make a policy decision.” Additionally, confer-
ences should not be viewed as ‘the tool’ to disseminate
the knowledge since many times they key knowledge
users are not present i.e., “Usually the Director General
and Deputy Director General and the Minister come,
greet and leave. Everyone knows it… How come re-
searchers do not realize that this will not lead to results
if the person who needs to hear isn’t there … I’m not
saying we should stop having conferences, but it can’t be
the tool (8(”.
Discussion
In this study, we investigated the views of health system
policymakers’ and senior executives involved in the pol-
icy development process in Israel on the use of HSPR to
inform decision making. Both the quantitative and the
qualitative components of the study demonstrated that
while there are many barriers in place, there are numer-
ous facilitators that are already in place and support
evidence informed policymaking and they can also be
capitalized on for future initiatives. The barriers primar-
ily focused on the currently available research and the
lack of some of its relevance and timeliness to support
decision making, the usually ineffective dissemination of
research, and interests of different stakeholder groups.
The main facilitator that was identified both in the
quantitative and the qualitative research was the strong
foundation of relationships and collaborations between
researchers and policymakers or decision makers. Partic-
ipants provided a wealth of suggestions regarding how
to improve the use of HSPR to support health policy-
making and decision making.
The diversity of respondents can be viewed as both a
strength and a limitation of the study- it provides us
with a wider context of many of the actors in the policy
making process, but, on the other hand, their divergent
perspectives and personal experiences can lead to differ-
ent opinions on the use of HSPR and its role in the pol-
icymaking process, thus obfuscating the results. While
we may note the differences in response rates for each
category of respondents, two issues must be taken into
consideration. Firstly, the number of potential respon-
dents in each category is relatively small, especially if we
integrate the different categories together (i.e. director
level- government, other-non-government, etc.) as well
Table 11 Suggestions to improve the use of HSPR in health policymaking in Israela (Continued)
3. Opportunities for official linkage and
exchange between policymakers and
researchers such as;
If you define in advance the role of decision maker, or an executive; if you make it a part of his roles
not only to provide services but also to create an interface with the Academy. So you generate, in
advance, an organizational commitment, even a physical one, for the purpose of learning, reading,
hearing and cooperation. .
• Conferences Periodic meetings with the NIHP. The Health Ministry has a level that knows what is happening at the
NIHP. At my level, which is an intermediate level, we don’t know… If there were conferences to the
middle levels… to see what you are researching, what you are doing, how it relates.
For me, this whole story of conferences and journal clubs is very helpful, but many policy makers
don’t see its importance of it and make time.
• Journal club/research clubs Periodic meetings – invite various organizations to present their fields of interest to the Health
Ministry, the HOMs management, all kinds of decision-makers. There are institutions such as Tel Aviv
University, Brookdale (Centre for Health Policy Research), Gertner (Institute for Epidemiology and
Health Policy Research), places like this, that can, once in a while, come and present their work in
these fields and to see what are the relevant components and where they can augment each other.
Formal meetings. To make some seminar or a consensus conference where policy makers will be
invited (usually there are only researchers in such consensus conferences) so a kind of sharing, joint
seminar....
4. Increased budget to support KTE Instead of investing 100 NIS in research, spend 90 on research and 10 on implementation…
aThe themes in the table are presented from the most common themes to the least common themes mentioned in the interviews
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as other subdivisions within each category, so that it is
likely that potential systematic biases may be oversha-
dowed by the individuality of each respondent’s unique
position. Secondly, the categorizations was based on the
respondents current position, or the one that they held
within the previous 5 years- many of the respondents
have a long history of different positions within the
healthcare system or the policy-making process, there-
fore their response may reflect experiences and perspec-
tives that place them into more than one category.
The biggest strength of this study is that, to our know-
ledge, this is the first study examining the views on the
use of HSPR by health system policymakers and and
senior executives involved in the policy development
process in Israel. Further strengths include that the
close-ended questions were built on a pre-existing and
validated instrument and that the survey was adminis-
tered face-to-face as opposed to online, thus promoting
a somewhat higher response rate. However, our survey is
not without limitations. The two main limitations are: a)
despite the fact that the researchers went to great
lengths and repeated attempts to recruit participants,
the response rate is lower than hoped and b) the survey
is based on self-reports and therefore, social desirability
bias cannot be excluded. These limitations may influence
both internal validity and the generalizability of the find-
ings to the broader population.
Another limitation of the study is that it asked respon-
dents to relate to the research-policy interface overall. It is
quite likely that the effectiveness of the interface varies
across institutions, policy area, type of research, etc. There
may also have been some differences in among various
types of respondents in their perceptions; however given
the relatively small sample size it is not possible to differ-
entiate the effects of those differences from just individual
variability. There are important opportunities for further
research to explore what accounts for the variation in the
effectiveness interface in Israel; both quantitative studies
and in-depth case studies can play an important role.
Some of the findings of this study are in alignment to
the findings of other international studies. Similar to
other studies, this study identified the need for the time-
liness and relevance of the research as well as the local
applicability of the research as factors that can influence
the uptake of research evidence [15, 39–41]. Further-
more, numerous papers and studies have been written
about the importance of relationships and collaboration
between researchers and decision makers which can fa-
cilitate the increase of evidence informed policymaking.
Barriers such as lack of personal contact and opportun-
ities to discuss challenges and research opportunities be-
tween researchers and knowledge users impede the use
of research in policymaking [15, 17, 39, 41–44]. The is-
sues uncovered in this research, while not new in the
field of KTE, are new to the Israeli context. These
findings provide insight as to the challenges experi-
enced in Israel and provide researchers and decision
makers with the necessary evidence to build interventions
to support the use of HSPR in policymaking and decision
making.
There are some differences as well between this study
and the international literature. One main difference is
with respect to the groups or factors that exert a strong
influence on the health policymaking process. In our
study, the three biggest influencing factors were limited
health funding, the health insurance funds and the
media; however, in other studies, other factors were
found to have a strong influence such as physician asso-
ciations, donor organizations or the values of governing
parties [13, 31]. Furthermore, in two other studies, about
half to two-thirds of the respondents agreed or strongly
agreed that research about problems related to healthcare
or health systems exerted a strong influence on the policy-
making process (46 % in the Eastern Mediterranean
Region and 66 % in Canada; the Canadian study focused
specifically on research related to healthcare providers),
while in our study only 19 % agreed or strongly agreed
with that statement [13, 31].
Also, based on the quantitative and the qualitative find-
ings, it is apparent that there are strong relationships be-
tween researchers and policymakers in Israel. This is in
contrast to the situation in many other countries where
these relationships appear to be less well developed. For
example, in one study from the Eastern Mediterranean re-
gion it was found that only 43 % of respondents agreed
that there are contact and collaborative relationships
between researchers and policymakers and/or decision
makers [13]. The relatively strong relationships in Israel
should be capitalized upon, as is elaborated below.
Numerous frameworks have been developed, describ-
ing an array of initiatives related to KTE, [25, 26, 45–50]
yet many of them operate at the individual or clinical
level and not at the country level. Lavis et al propose a
framework to assist in assessing country level efforts re-
lated to KTE and provide insight as to which elements a
health system should have in place in order to facilitate
the use of research in policymaking [25]. There are
seven main elements which are:
1) Climate for research use (i.e. ensuring a climate where
researchers, policymakers, and decision makers value
the use of research in policy and decision making)
2) Research production (i.e. ensuring appropriate
capacity (i.e. financial and human) to conduct
highly relevant research)
3) Push Efforts (i.e. efforts undertaken to push the
applicable research out to potential users through
appropriate channels)
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4) Facilitating Pull Efforts (i.e. ensuring the necessary
infrastructure and tools are in place so research
can be readily and easily accessible)
5) Pull Efforts (i.e. efforts undertaken by users of
research to acquire, assess, adapt and apply the
appropriate research)
6) Linkage and exchange efforts (i.e. initiatives to
create open relationships and dialogues between
the research producers and the research users)
7) Evaluation efforts (i.e. evaluation of KT initiatives).
Based on this research, policymakers in Israel per-
ceive that the linkage and exchange efforts exist in
Israel and there is a strong foundation on which to
build upon. Strong links between policymakers, stake-
holders, and researchers can enhance the transfer of re-
search into practice [51]. Linkage and exchange efforts
fundamentally occur when there are positive relation-
ships between research producers and knowledge users,
which seems to be the case in Israel [52].
However, policymakers identified the biggest chal-
lenges to be within the research production and push ef-
forts. With respect to research production, the quality of
the research, its topical relevance, its operational useful-
ness, the solutions or recommendations associated with
the research, and the credibility of the source are all im-
portant characteristics that can enhance the use of re-
search in policymaking [48, 53, 54]. Health systems need
to ensure that they have the capacity to conduct re-
search and fund the creation of new knowledge [55].
Furthermore, changes are needed so that local stake-
holders such as policymakers and decision makers can
have influence in determining the nature, quality and ap-
plicability of the research being conducted [55]. Owner-
ship of research and research ideas by stakeholders are
also important [53]. If the Israeli health system wishes to
support the creation of new knowledge that is applicable,
future initiatives should focus on establishing regular pri-
ority setting processes with researchers, stakeholders, and
policy makers, funding new research in the form of part-
nerships between researchers and knowledge users or
health services agencies, and ensuring the overall capacity
to conduct or commission research [20, 25, 56].
With respect to push efforts, ensuring the effective
dissemination of research findings is essential. The push
efforts that researchers or intermediary groups under-
take can bring research evidence about an issue to the
forefront and to the attention of policymakers and in-
form the policy development and implementation pro-
cesses [12]. The messengers and the packaging of the
research are important characteristics to consider [41,
53], and were identified by participants as interventions
to consider in improving the dissemination of study
findings. Traditionally, researchers disseminate their
findings via publications and conferences; these are im-
portant initiatives but primarily contain the research
findings within academic circles. ‘Pushing’ the know-
ledge out to users requires re-packaging of information
and highlighting actionable, jargon-free messages [41].
To have an impact, research findings must be translated
and adapted to specific contexts and situations [53]. De-
veloping applied products and tools that help knowledge
users see the relevance and usefulness of the research is
a factor that can affect the successful transfer of research
into practice [22, 41, 57]. Examples of push efforts are
identifying actionable messages arising from research,
fine-tuning the messages for different user groups, work-
ing with credible messengers for each group to dissemin-
ate the messages, supporting decision making and actions
associated with the messages, and developing media re-
leases for the actionable messages, and training re-
searchers to develop their capacity to create, disseminate
and execute evidence informed push efforts [25].
What is interesting to note is that most of the areas
where policymakers identified a need for improvement fall
within the responsibilities of the researchers. Most re-
searchers that focus on health systems and policy research
in Israel have acknowledged that they are minimally in-
volved in KTE activities [34]. However, while increasing
initiatives both within research production and push ef-
forts to improve the use of HSPR in decision making is
important, there are initiatives that can be undertaken by
policymakers and decision makers as well.
Conclusion
This research demonstrated that health systems policy-
makers in Israel perceive to have strong relationships
with researchers; however there is room to improve on
these collaborations e.g., partnering in research projects
to ensure their relevance. Furthermore, health system
policymakers seem to be interested in receiving relevant
research in an effective format and are open to using re-
search in decision making. However, providing access to
relevant material and assisting target audiences to acquire
and use research is rarely done. KTE is a fairly new area in
Israel and therefore the level of KTE activities is not very
high. Health system and policy researchers in Israel need
to be given a deeper understanding of the benefits and po-
tential advantages of KTE in an organized and systematic
way and interventions need to be implemented and evalu-
ated to determine the effectiveness in the Israeli context.
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